World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
86
Citations
26425
World Ranking
2966
National Ranking
63

Medicine

D-Index
89
Citations
27576
World Ranking
12742
National Ranking
176

Overview

Francesco Bertoni is affiliated with the Institute of Oncology Research in Switzerland, contributing extensively to the fields of medicine and biochemistry, genetics, and molecular biology. Their research output is especially prominent in molecular biology, oncology, pathology and forensic medicine, genetics, and immunology.

The scientist's work focuses primarily on areas including lymphoma diagnosis and treatment, chronic lymphocytic leukemia research, and CAR-T cell therapy research. Additional topics cover immune cell function and interaction, protein degradation and inhibitors, ubiquitin and proteasome pathways, and HER2/EGFR in cancer research.

Frequent co-authors in their publications include:

  • Luciano Cascione
  • Alberto J. Arribas
  • Emanuele Zucca
  • Filippo Spriano
  • Davide Rossi

Their research has been published in multiple venues, with the highest number of publications appearing in:

  • Hematological Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Research
  • Molecular Cancer Therapeutics
  • European Journal of Cancer

Selected recent papers featuring either collaborative or associated work include:

  • The Essentials of Marine Biotechnology, 2021, Frontiers in Marine Science
  • Marine Anticancer Agents: An Overview with a Particular Focus on Their Chemical Classes, 2020, Marine Drugs
  • A New Network for the Advancement of Marine Biotechnology in Europe and Beyond, 2020, Frontiers in Marine Science
  • Overcoming PARPi resistance: Preclinical and clinical evidence in ovarian cancer, 2021, Drug Resistance Updates
  • Genetic and phenotypic attributes of splenic marginal zone lymphoma, 2021, Blood

Best Publications

  • Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells.

    Giorgio Napolitani;Andrea Rinaldi;Francesco Bertoni;Federica Sallusto

  • Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma

    Mara Compagno;Wei Keat Lim;Adina Grunn;Subhadra V. Nandula

  • Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation

    Giulia Fabbri;Silvia Rasi;Davide Rossi;Vladimir A. Trifonov

  • Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia

    Davide Rossi;Silvia Rasi;Valeria Spina;Alessio Bruscaggin

  • Primary extranodal non-Hodgkin's lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas

    E. Zucca;E. Roggero;F. Bertoni;F. Cavalli

  • Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness.

    Davide Rossi;Alessio Bruscaggin;Valeria Spina;Silvia Rasi

  • Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma.

    Ramona Crescenzo;Ramona Crescenzo;Francesco Abate;Francesco Abate;Francesco Abate;Elena Lasorsa;Fabrizio Tabbo;Fabrizio Tabbo

  • The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation

    Davide Rossi;Valeria Spina;Clara Deambrogi;Silvia Rasi

  • The coding genome of splenic marginal zone lymphoma: Activation of NOTCH2 and other pathways regulating marginal zone development

    Davide Rossi;Vladimir Trifonov;Marco Fangazio;Alessio Bruscaggin

  • BET Proteins as Targets for Anticancer Treatment.

    Anastasios Stathis;Francesco Bertoni

  • Disruption of BIRC3 associates with Fludarabine Chemorefractoriness in TP53 Wild Type Chronic Lymphocytic Leukemia

    Davide Rossi;Marco Fangazio;Silvia Rasi;Tiziana Vaisitti

  • The gastric marginal zone B-cell lymphoma of MALT type

    Emanuele Zucca;Francesco Bertoni;Enrico Roggero;Franco Cavalli

  • Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy.

    Giovanni Martinelli;Daniele Laszlo;Andrés J M Ferreri;Giancarlo Pruneri

  • Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome

    Ekaterina Chigrinova;Andrea Rinaldi;Ivo Kwee;Ivo Kwee;Davide Rossi

  • Molecular Analysis of the Progression from Helicobacter pylori–Associated Chronic Gastritis to Mucosa-Associated Lymphoid-Tissue Lymphoma of the Stomach

    Emanuele Zucca;Francesco Bertoni;Enrico Roggero;Giovanna Bosshard

  • The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs

    Michela Boi;Eugenio Gaudio;Paola Bonetti;Ivo Kwee

  • Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma.

    Valeria Spina;Alessio Bruscaggin;Annarosa Cuccaro;Maurizio Martini

  • The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance.

    Emanuele Zucca;Francesco Bertoni

  • The NF-κB negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas

    Urban Novak;Andrea Rinaldi;Ivo Kwee;Subhadra V. Nandula

  • Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing

    Giorgio Napolitani;Andrea Rinaldi;Francesco Bertoni;Federica Sallusto

Frequent Co-Authors

Emanuele Zucca
Emanuele Zucca Universita della Svizzera Italiana
Gianluca Gaidano
Gianluca Gaidano University of Eastern Piedmont Amadeo Avogadro
Davide Rossi
Davide Rossi European Society for Medical Oncology
Giorgio Inghirami
Giorgio Inghirami Cornell University
Maurilio Ponzoni
Maurilio Ponzoni Vita-Salute San Raffaele University
Valter Gattei
Valter Gattei University of Trieste
Antonino Neri
Antonino Neri University of Milan
Daniela Capello
Daniela Capello University of Eastern Piedmont Amadeo Avogadro
Stefano Pileri
Stefano Pileri European Institute of Oncology
Miguel A. Piris
Miguel A. Piris Instituto de Salud Carlos III

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry in the USA opens doors to a wide range of online degrees and flexible career pathways. Prospective students can explore specialized options, such as the best dietetics programs to build expertise in nutrition and clinical dietetics, a field closely linked to biochemistry.

For those interested in healthcare support roles, enrolling in an online medical assisting school provides a practical pathway into patient care and clinical work. Medical assistants can further advance their careers through ma to lpn programs, which offer a transition into nursing and expanded clinical responsibilities.

Those seeking a more comprehensive grounding in biological sciences may prefer earning an online bachelor's degree in biology, ideal for students needing flexibility or accelerated study options. These alternative and stackable credentials make it easier to align your educational journey with your specific career goals in the ever-evolving life sciences landscape.

Best Scientists Citing Francesco Bertoni

Trending Scientists

Recently Published Articles